BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24076366)

  • 21. Attenuation of the aggregation and neurotoxicity of amyloid-β peptides by catalytic photooxygenation.
    Taniguchi A; Sasaki D; Shiohara A; Iwatsubo T; Tomita T; Sohma Y; Kanai M
    Angew Chem Int Ed Engl; 2014 Jan; 53(5):1382-5. PubMed ID: 24339209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease.
    Portelius E; Olsson M; Brinkmalm G; Rüetschi U; Mattsson N; Andreasson U; Gobom J; Brinkmalm A; Hölttä M; Blennow K; Zetterberg H
    J Alzheimers Dis; 2013; 33(1):85-93. PubMed ID: 22886024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A synthetic peptide corresponding to a region of the human pericentriolar material 1 (PCM-1) protein binds β-amyloid (Aβ1-42 ) oligomers.
    Chakravarthy B; Ménard M; Brown L; Hewitt M; Atkinson T; Whitfield J
    J Neurochem; 2013 Aug; 126(3):415-24. PubMed ID: 23432034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On-line high-performance liquid chromatography/mass spectrometric investigation of amyloid-beta peptide variants found in Alzheimer's disease.
    Thompson AJ; Lim TK; Barrow CJ
    Rapid Commun Mass Spectrom; 1999; 13(23):2348-51. PubMed ID: 10567933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
    Kino R; Araya T; Arai T; Sohma Y; Kanai M
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. O-acyl isopeptide method: development of an O-acyl isodipeptide unit for Boc SPPS and its application to the synthesis of Aβ1-42 isopeptide.
    Yoshiya T; Uemura T; Maruno T; Kubo S; Kiso Y; Sohma Y; Kobayashi Y; Yoshizawa-Kumagaye K; Nishiuchi Y
    J Pept Sci; 2014 Sep; 20(9):669-74. PubMed ID: 24889810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoaspartate-containing amyloid precursor protein-derived peptides alter efficacy and specificity of potential beta-secretases.
    Böhme L; Hoffmann T; Manhart S; Wolf R; Demuth HU
    Biol Chem; 2008 Aug; 389(8):1055-66. PubMed ID: 18979630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.
    Lewczuk P; Esselmann H; Groemer TW; Bibl M; Maler JM; Steinacker P; Otto M; Kornhuber J; Wiltfang J
    Biol Psychiatry; 2004 Mar; 55(5):524-30. PubMed ID: 15023581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro.
    Zhou B; Li CL; Hao YQ; Johnny MC; Liu YN; Li J
    Bioorg Med Chem; 2013 Jan; 21(2):395-402. PubMed ID: 23245572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid profile of amyloid beta peptides in patients with Alzheimer's disease determined by protein biochip technology.
    Maddalena AS; Papassotiropoulos A; Gonzalez-Agosti C; Signorell A; Hegi T; Pasch T; Nitsch RM; Hock C
    Neurodegener Dis; 2004; 1(4-5):231-5. PubMed ID: 16908995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A commonly used Drosophila model of Alzheimer's disease generates an aberrant species of amyloid-β with an additional N-terminal glutamine residue.
    Allan K; Perez KA; Barnham KJ; Camakaris J; Burke R
    FEBS Lett; 2014 Oct; 588(20):3739-43. PubMed ID: 25171862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineered non-fluorescent Affibody molecules facilitate studies of the amyloid-beta (Aβ) peptide in monomeric form: low pH was found to reduce Aβ/Cu(II) binding affinity.
    Lindgren J; Segerfeldt P; Sholts SB; Gräslund A; Karlström AE; Wärmländer SK
    J Inorg Biochem; 2013 Mar; 120():18-23. PubMed ID: 23262458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's Abeta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Toropygin IY; Kugaevskaya EV; Mirgorodskaya OA; Elisseeva YE; Kozmin YP; Popov IA; Nikolaev EN; Makarov AA; Kozin SA
    Rapid Commun Mass Spectrom; 2008; 22(2):231-9. PubMed ID: 18085519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Cu-amyloid-β by using bifunctional peptides with β-sheet breaker and chelator moieties.
    Jensen M; Canning A; Chiha S; Bouquerel P; Pedersen JT; Østergaard J; Cuvillier O; Sasaki I; Hureau C; Faller P
    Chemistry; 2012 Apr; 18(16):4836-9. PubMed ID: 22422637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing the role of backbone hydrogen bonding in beta-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions.
    Gordon DJ; Meredith SC
    Biochemistry; 2003 Jan; 42(2):475-85. PubMed ID: 12525175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that a synthetic amyloid-ß oligomer-binding peptide (ABP) targets amyloid-ß deposits in transgenic mouse brain and human Alzheimer's disease brain.
    Chakravarthy B; Ito S; Atkinson T; Gaudet C; Ménard M; Brown L; Whitfield J
    Biochem Biophys Res Commun; 2014 Mar; 445(3):656-60. PubMed ID: 24569075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ monitoring Alzheimer's disease β-amyloid aggregation and screening of Aβ inhibitors using a perylene probe.
    Li M; Zhao C; Yang X; Ren J; Xu C; Qu X
    Small; 2013 Jan; 9(1):52-5. PubMed ID: 22976818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.